Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Healthtrust
Cipla
Fuji
AstraZeneca
Teva
Queensland Health
Harvard Business School

Generated: April 20, 2018

DrugPatentWatch Database Preview

PANDEL Drug Profile

« Back to Dashboard

When do Pandel patents expire, and what generic alternatives are available?

Pandel is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PANDEL is hydrocortisone probutate. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrocortisone probutate profile page.
Summary for PANDEL
Drug patent expirations by year for PANDEL
Pharmacology for PANDEL
Synonyms for PANDEL
(11|A)-11-Hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregn-4-ene-3,20-dione
(1S,2R,10S,11S,14R,15S,17S)-17-HYDROXY-2,15-DIMETHYL-5-OXO-14-[2-(PROPANOYLOXY)ACETYL]TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL BUTANOATE
[(8S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-propanoyloxyacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-propanoyloxyacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
11beta-Hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregn-4-ene-3,20-dione
11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate 21-propionate
11beta,17,21-trihydroxypregn-4-ene-3,20-dione17-butyrate21-propionate
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione 17-butyrate, 21-propionate
17-Butyryloxy-11-beta-hydroxy-21-propionyloxy-4-pregnene-3,20-dione
17|A-Butyryloxy-11|A-hydroxy-21-propionyloxy-4-pregnene-3,20-dione
72590-77-3
AC1L1BGY
AC1LCS5W
API0002948
C13358
C28H40O7
CAS-72590-77-3
CHEBI:31675
CHEMBL1200953
CORTISOL, 17-BUTYRATE, 21-PROPIONATE
D01886
DSSTox_CID_28529
DSSTox_GSID_48603
DSSTox_RID_82801
DTXSID3048603
EINECS 276-726-9
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone buteprate
Hydrocortisone buteprate [USAN]
Hydrocortisone butyrate propionate
Hydrocortisone butyrate propionate (JAN)
Hydrocortisone butyrate propionate [JAN]
Hydrocortisone probutate
Hydrocortisone probutate (USAN)
Hydrocortisone probutate [USAN]
LMST02030128
LS-54998
NCGC00183276-01
O6550D6K3A
Pandel (TN)
PL009757
Pregn-4-ene-3,20-dione, 11-hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)-, (11-beta)-
Pregn-4-ene-3,20-dione, 11-hydroxy-17-(1-oxobutoxy)-21-(1-oxopropyl)-, (11beta)-
Pregn-4-ene-3,20-dione,11-hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)-, (11b)-
Pregn-4-ene-3,30-dione, 11-beta,17,21-trihydroxy-, 17-butyrate, 21-propionate
SCHEMBL4778
Tox21_112938
TS 408
TS-408
UNII-O6550D6K3A
ZINC4213519

US Patents and Regulatory Information for PANDEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PANDEL hydrocortisone probutate CREAM;TOPICAL 020453-001 Feb 28, 1997 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Citi
Healthtrust
Johnson and Johnson
Chubb
Harvard Business School
UBS
Accenture
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.